Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 7;19(10):e0308666.
doi: 10.1371/journal.pone.0308666. eCollection 2024.

Impact of GnRH antagonist pretreatment on oocyte yield after ovarian stimulation: A retrospective analysis

Di Guardo Federica  1   2 , Sylvie De Rijdt  1 , Annalisa Racca  1   3 , Panagiotis Drakopoulos  1   4 , Shari Mackens  1 , Laurence Strypstein  1 , Herman Tournaye  1   5 , Michel De Vos  1   5 , Christophe Blockeel  1
Affiliations

Impact of GnRH antagonist pretreatment on oocyte yield after ovarian stimulation: A retrospective analysis

Di Guardo Federica et al. PLoS One. .

Erratum in

Abstract

The study investigates whether a 3-day pretreatment course with a GnRH antagonist in the early follicular phase has an impact on the number of retrieved COCs in a GnRH antagonist stimulation protocol. This is a retrospective single center crossover study involving women who did not conceive after one GnRH antagonist stimulation cycle ("standard cycle") and proceeded with another GnRH antagonist stimulation cycle preceded by early administration of GnRH antagonist for 3 days ("pretreatment cycle") with fresh embryo transfer or frozen embryo transfer. 430 patients undergoing 860 cycles were included. The mean female age was 34.4 ± 4.8 years. Indications for fertility treatment included unexplained infertility (34.3%), male-factor infertility (33.3%), age (16.9%), PCOS (8.2%), tubal (4.7) and endometriosis (2.6%). All cycles were divided into two groups: group 1 (standard, 430 cycles) and group 2 (pretreatment, 430 cycles). The mean duration of stimulation was similar in both groups (10.3 vs 10.3 days, p = 0.28). The starting dose of gonadotropin (234.9 vs 196.8 IU, p<0.001), total amount of gonadotropin used (2419 vs 2020 IU, p<0.001), the total number of retrieved COCs (10 vs 7.8 p<0.001) and the number of mature oocytes (8 vs 5.8 p<0.001) were significantly higher in group 2 than in group 1. The Generalized estimating equation (GEE) regression analysis showed that the pretreatment strategy had a significant positive effect on the number of COCs (coefficient 2.4, p <0.001 after adjusting for known confounders (age, indication, stimulation dose, type, and duration of stimulation). In conclusion, A 3-day course of GnRH antagonist pretreatment increases the number of COCs obtained after ovarian stimulation.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Van Hooren HG, Fischl F, Aboulghar, Marès, Nicollet B, Behre HM, et al.. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod [Internet]. 2001. [cited 2022 Sep 16];16(4):644–51. Available from: https://pubmed.ncbi.nlm.nih.gov/11278211/ doi: 10.1093/humrep/16.4.644 - DOI - PubMed
    1. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. In: Cochrane Database of Systematic Reviews [Internet]. John Wiley & Sons, Ltd; 2006. [cited 2022 Sep 16]. Available from: https://pubmed.ncbi.nlm.nih.gov/16855976/ - PubMed
    1. Devroey P, Aboulghar M, Garcia-Velasco J, Griesinger G, Humaidan P, Kolibianakis E, et al.. Improving the patient’s experience of IVF/ICSI: A proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment [Internet]. Vol. 24, Human Reproduction. Oxford University Press; 2009. [cited 2022 Sep 16]. p. 764–74. Available from: https://pubmed.ncbi.nlm.nih.gov/19153090/ - PubMed
    1. Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis [Internet]. Vol. 12, Human Reproduction Update. Hum Reprod Update; 2006. [cited 2022 Sep 16]. p. 651–71. Available from: https://pubmed.ncbi.nlm.nih.gov/16920869/ - PubMed
    1. Fanchin R, Salomon L, Castelo-Branco A, Olivennes F, Frydman N, Frydman R. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod [Internet]. 2003. [cited 2022 Sep 16];18(12):2698–703. Available from: https://pubmed.ncbi.nlm.nih.gov/14645194/ doi: 10.1093/humrep/deg516 - DOI - PubMed

Substances

LinkOut - more resources